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Background. The incidence of tuberculosis (TB) disease in Greenland doubled in the 1990s. To combat the
increase, national TB interventions were initiated in 2000 and strengthened in 2007.
Objective. To determine whether the effect of interventions could be detected, we estimated the TB disease risk
among children515 years before and after interventions were implemented.
Design. For a study cohort, we recruited all children 515 years of age included in the Greenlandic Civil
Registration System (CRS) from 1990 to 2010. The CRS identifier was used to link cohort participants with
TB cases identified based on the Greenlandic National TB registry. Bacille Calmette Guerin (BCG) vacci-
nation status was identified throughyear of birth, as BCG was offered to newborns born either before 1991 or
after 1996. Years with interventions were defined as 20002006 (primary interventions) and 20072010
(intensified interventions). Risk of TB was estimated using Poisson regression.
Results. The study included 35,858 children, of whom 209 had TB disease. The TB disease incidence decreased
after interventions were implemented (20072010: IRR [incidence rate ratios] 0.62, 95% CI: 0.390.95,
p0.03, compared with the 19951999 period). The TB disease risk was inversely associated with BCG
vaccination (IRR: 0.54, 95% CI: 0.410.72, pB0.001).
Conclusions. Years with national TB interventions in Greenland, including neonate BCG vaccination, are
associated with a lower TB disease incidence among children 515 years of age.
Keywords: epidemiological study; tuberculosis disease; tuberculosis control; children; Greenland
*Correspondence to: Emilie Birch, Department of Epidemiology Research, Statens Serum Institut,
Artillerivej 5, DK-2300 Copenhagen S, Denmark, Email: emilie_birch@hotmail.com
Received: 4 May 2014; Revised: 15 June 2014; Accepted: 15 June 2014; Published: 11 July 2014
I
n the 1950s, the Inuit population in Greenland pre-
sented the highest tuberculosis (TB) disease incidence
rates (IR) ever observed worldwide with an IR of
2,200 cases per 100,000 inhabitants in 1952 (1). Subse-
quently, TB interventions were initiated including inaugu-
ration of Dronning Ingrids Sanatorium (SANA) in Nuuk,
Greenland, in 1954, a hospital with 211 beds exclusively
for treating TB patients. From 1955 to 1971, a specialized
TB ship sailed the coastline offering bi-annual population-
based chest x-ray screenings. The Bacille Calmette Guerin
Vaccination (BCG) was introduced in 1949 and became a
nationwide offer for neonates from 1955 (2). The colla-
borative interventions dramatically reduced the TB disease
IR, which came to an all-time low of 25 cases per 100,000
inhabitants in 1983 (3).
With the declining incidence of TB disease, the Green-
landic TB interventions were phased out and the last
remaining intervention, the BCG vaccine to neonates, was
removed from the vaccination programme in 1991. How-
ever, from the 1990s, the TB disease IR increased again
(3). In addition to a doubling of the overall TB incidence,
numerous cases of TB meningitis among young children
with fatal outcomes were registered. These fatal cases led
to the reintroduction of BCG vaccination offered to all
newborns in 1997.
In the year 2000, the Greenland Home Rule Govern-
ment that was formed in 1979 introduced its first national
TB intervention programme in response to the increased
TB disease incidence in the 1990s. TB interventions
in the 1950s were instituted by the Danish Government.
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cluded the formation of a central TB group to coordinate
the national interventions.
National guidelines were formed describing procedures
for diagnosis, treatment, contact tracing and screening.
A national TB nurse was recruited for countrywide co-
ordination and training of staff (3). A central monitoring
unit collecting TB notifications from all districts was
established (4). In the early 2000s, a study documented
that 8% of Greenlandic school children were infected
with Mycobacterium tuberculosis infection (MTI) (5). The
study results led to the implementation of an intensified
intervention strategy in 2007. The additional interven-
tions included yearly MTI screening of school children,
public TB campaigns and publication of TB training
material for health workers (6,7).
The purpose of the present study was to determine
whether 10 years of national TB interventions are asso-
ciated with any change in childhood TB disease incidence
in Greenland.
Materials and methods
Study design and population
A retrospective cohort study was conducted. The study
population consisted of all children living in Greenland
under the age of 16 years in the period 1 January 1990 to
31 December 2010. Children born in this period were
included and children turning 16 were removed.
At birth, all Greenlandic citizens are registered in the
Danish Civil Registration System (CRS) and allocated a
personal identifier, which allows follow-up in all public
registries. Information on age, sex and place of birth
of participants was collected from the CRS identifier.
Only children born in Greenland were included. Follow-
up time was contributed until; TB notification, emigra-
tion from Greenland or Denmark, or until the end of the
study period, whichever came first.
TB is a mandatory notifiable disease in Greenland
and is reported to the National Board of Health in
Greenland. Cases are reported on an individual level
using the CRS identifier and data are stored in the TB
registry. Using the personal CRS identifier, all TB cases
among study participants were sought in the Greenlandic
TB registry for the period 19902010.
In Greenland, the TB disease diagnosis is made based
on clinical criteria combined with laboratory analysis,
such as positive Mycobacterium tuberculosis (Mtb) micro-
scopy and/or culture. Mantoux test or QuantiFERON†-
TB Gold test may be done as part of the evaluation (8).
The diagnosis is, however, not easy in children because
they may not have symptoms that are more typically seen
in adults, such as cough (9). The diagnosis is often made
clinically without a positive Mtb microscopy. Bacteria in
sputumaswellasx-raychangesareoftendifficulttodetect
in children, but are easier to detect when the children are
older at the time of diagnosis (10).
BCG vaccination status for each child was determi-
ned by the year of birth. The official BCG vaccination
programme in Greenland mandated vaccination of all new-
borns born either before 1991 or after 1996 (2). Children
born from 1991 to 1996 are therefore considered not to be
vaccinated, while children born in 1990 and 19972010
are considered to be BCG vaccinated.
Statistical methods
To determine whether TB disease incidence was asso-
ciated with TB interventions, we calculated TB disease
incidence in the cohort of children in sub-periods from
1990 to 2010, where 19901999 was the pre-intervention
period, and 20002010 the intervention period. As inter-
ventions were intensified in 2007, the intervention period
was sub-divided into the periods  20002006 and 2007
2010. The pre-intervention period was correspondingly
divided into the 2 periods  19901994 and 19951999.
The period 19951999 was used as reference due to the
high TB disease incidence in this period.
All included children contribute person years individu-
ally using the entry and exit dates as described. IR were
calculated as the numberof cases dividedwith the number
of observed person years scaled appropriately.
The incidence rate ratios (IRRs) were calculated using
log-linear Poisson regression models adjusted for age,
sex and BCG status as the yearly number of new TB cases
by year of follow-up. The age adjustment was made
with cubic splines restricted to be linear in the tails (11).
SAS PROC Genmod was used (SAS version 9.3, SAS
Institute, Cary, NC, USA).
Age, sex and BCG vaccination status were tested
together with the periods in a multivariable regression
analysis, since these factors could influence TB outcome.
We not only adjusted the multivariable model with age
using splines but also showed the adjusted effects of age
in groups not using splines. Further, we also performed a
trend test for the age effect (age in years).
Ethical considerations
The studies fulfilled the Helsinki Declaration II. The Com-
mission for Scientific Research in Greenland approved
the studies (Approval No. 2014-6). Data were stored in
accordance with the regulation of the Danish Data Pro-
tection Agency. The studies were carried out in accor-
dance with the STROBE statements.
Results
The study included 35,858 children, hereof 51% males.
In the study period from January 1990 to December 2010,
the total number of TB cases among children younger
than 16 were 209, of whom 87 (42%) were notified in the
period 19901999, 93 (44%) in the period 20002006 and
23 (14%) from 2007 to 2010.
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4 different periods are given in Table I. The IRRs were
significantly lower in the first pre-intervention period
19901994 and in the second post-intervention period
20072010 compared with the periods immediately be-
fore (19951999) and after initiation of interventions
(20002006), which showed no difference in incidence.
Table II illustrates that the prevalence of TB disease
was highest among girls with an IRR of 1.37, P0.03.
BCG vaccination in the neonatal vaccination programme
was associated with a lower TB IRR (0.54, PB0.001).
Age trend in risk of TB
There was an adjusted linear trend for age with an IRRof
1.04, P0.02.
Discussion
Impact of TB interventions
This study reports that the increasing incidence in TB
disease among children in Greenland seen through the
1990s came to a halt in the period 20002006 and de-
creased from 2007. This coincides with the introduction
of interventions against TB in 2000 and the strengthening
of the programme from 2007. Obviously, it is difficult to
claim a causal association between TB interventions and
TB disease incidence based on temporal associations, but
it is striking that the epidemic stopped during the first
period of interventions and that the incidence decreased
during the second. An actual decrease in incidence im-
mediately following initiation of TB interventions in 2000
would not have been likely, as the effort to control TB is a
long-term effort (5,12). Therefore, while it seems reason-
able to assume that TB interventions have had an impact
on TB disease incidence in Greenland, it is difficult to
determine whether the decrease in incidence after 2007
is the result of strengthening interventions or a delayed
effect of the initial interventions in 2000. For the same
reason, it is difficult to identify the contribution of indi-
vidual elements of the intervention programmes.
Three factors were significantly associated with in-
creased risk of TB disease in our population  female sex,
increasing age and being born in a period without
neonatal BCG vaccination (19911996). While sex and
age distributions were not affected by the intervention
programmes, the reintroduction of the BCG vaccination
may have played a role in the reduced TB incidence after
2000. Neonatal BCG vaccination was stopped in 1991
in Greenland and reintroduced in 1997. Worldwide, the
effect of the BCG vaccination is much debated and vacci-
nation has shown variable efficacy against TB in different
settings (13,14). However, there is evidence that BCG has
an effect in preventing disseminated TB disease in young
children (15,16). It is possible that the reintroduction of
the neonatal BCG vaccination may, with or without the
other TB interventions from 2000, have played a role in
the prevention of TB in Greenland.
Greenlandic girls had a significantly higher risk of
TB disease comparedwith Greenlandic boys. This finding
contrasts with the generally well-known sex distribution
for TB disease among adults according to which men have
a higher risk of TB disease than women (17). The higher
TB risk among men is not strictly a sex-effect but rather
presumed to be related to certain social factors found
in higher frequencies in men, for example, alcohol abuse
(18). New DNA-typing-based studies report that TB trans-
mission most often happens within the household (19).
A possible explanation of our study findings of a higher
risk among Greenlandic girls could be that Greenlandic
girls spend more time inside the house, leaving them
more exposed to MTI from TB-infected members of the
household.
The risk of TB disease increased with age by 4% per
year, reflecting increased risk of TB disease with increas-
ing period of exposure. The figure of 4% is high. The
figure of 4% covers the whole period 19902010 and is
obviously dependent on time.
We previously found an annual risk of MTI (i.e. ex-
posure to Mtb measured by Mantoux test or Quanti-
FERON†-TB Gold test) of 0.8% per year in children in
Greenland in the period 20062007 (5).
Table I. TB disease among children in Greenland, 1990 to 2010, stratiﬁed by period
Period
a TB cases IRR
b 95% CI
c p
d IR
e
19901994 23 0.47 (0.280.75) 0.002 29.0 (18.7,42.5)
19951999 64 1 (Ref.)  75.8 (58.7,95.9)
20002006 93 1.05 (0.761.45) 0.78 81.6 (66.1,99.3)
20072010 29 0.62 (0.390.95) 0.03 49.0 (33.3,69.1)
Total 209 0.0004
aAdjusted for sex, vaccination period and age with splines.
bIncidence rate ratios.
cConfidence intervals.
dTest for homogeneity.
eIncidence rates per 100,000 person years.
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Data were gathered from national registers. The popula-
tioniswell-describedwitheverycitizenofGreenlandbeing
registered with vital information in the weekly updated
person-identifiable national CRS. Also, all Greenlandic
children have the possibility to appear in the National
Greenlandic TB registry, as it holds nationwide infor-
mation on all known cases of TB disease in Greenland.
However, it cannot be ascertained that all cases of TB
disease in Greenland are diagnosed. Like every other
disease, a TB diagnosis depends on the patients seeking
medical help, doctors’ diagnoses and reporting to the
system and possible contact tracing. However, while
underdiagnosis of the TB disease might have been the
case in the 1990s, possibly suggested by the observation
of very variable risks of transmission in Greenland (20),
the increased attention to TB both from the medical
system and the public as well as the contact tracing make
underreporting of TB disease less likely after 2000. If
increased awareness had led to more cases being recog-
nized after 2000 this would have led to a higher inci-
dence after this time. Therefore, the actual reduction in
incidence seen after 2000 indicates a true decrease in risk
following introduction of interventions.
TB in Greenland
Greenland’s healthcare system is comparable with those
of other Western countries. The population is well-
defined and despite scattered settlements it is possible to
organize focused preventing health interventions. Despite
this fact, the TB disease incidence is similar to that in
developing countries. The explanation is probably multi-
factorial. One reason could be that the cold climate in
Greenland favours indoor activities, leading to a higher
risk of MTI through longer lifespan of bacteria indoors
and easier Mtb transmission through less ventilated houses.
Another reason could be the Inuit tradition of large
families living in small households with poor sanitary
standards. A debated, but unsolved, issue is whether
genetic factors predispose the Inuit population to higher
risks of TB disease (5).
Further efforts are needed to reduce the TB disease
incidence in Greenlandic children. Experts from WHO
visited Greenland in 2010 to evaluate the TB situation
and found an unacceptably high incidence of TB disease
(21). Thus, TB interventions from 2000 do not seem suffi-
cient to fulfil the ambitions of WHO to reduce the inci-
dence of TB disease by 50% by 2015 compared with 1990
(22). For this reason, a new intervention programme,
‘‘National TB strategy 20122016,’’ has been implemented
(8). This programme focuses especially on information
campaigns, diagnostics and treatment in the local envi-
ronment with employment of local TB nurses and TB
coordinators.
Time will show if the new intervention is capable
of further controlling and reducing TB disease among
children in Greenland. It has previously been possible to
control TB in Greenland and to achieve impressive
results within a few decades. Replication of such achieve-
ments should be possible by nationwide campaigns.
Conclusions
This study indicates that the first 10 years of Greenlandic
National TB interventions have had a positive impact
on TB disease in Greenlandic children with significantly
lower IRs after initiation of interventions. While the in-
creasing incidence seen throughout the 1990s came to a
halt following the first interventions in 2000, the inci-
dence was reduced after a strengthening of interventions
in 2007.
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